* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Peptides are a class of compounds consisting of multiple amino acids linked by peptide bonds, usually consisting of 10 to 100 amino acid molecules, combined in the same way as proteins, with a relative molecular mass below 10 kDa. Peptides, as a modality of the drugs, are now widely used in the prevention, diagnosis and treatment of diseases such as oncology, diabetes and AIDS.
Creative Peptides is a leading CDMO providing custom peptide services from early development to commercial production, supporting pharmaceutical and biotech companies in the development and manufacture of proprietary and generic peptide active pharmaceutical ingredients (APIs).
1. New Drug Application (NDA)
Supply of raw materials for clinical research, new drug support, regulatory support
2. Generic drug project (ANDA)
The special nature of peptides production process leads to its inability to use the development and production facilities of small molecule drugs and biologicals. From the cost point of view, it is an economical choice for peptide-based biotech companies to choose to cooperate with CDMO companies that have a complete set of facilities for peptide drug research and production.
Peptide drugs are very different from small molecule drugs and biologics in terms of pharmacological research, including process development, impurity research, structure identification, etc. General biotech and pharmaceutical companies have limited pipeline to layout peptide drugs, therefore, professional peptide CDMO is a good choice for co-development, which can reduce the failure risk and help peptide drugs enter the market faster.
The compliance requirement of peptide drugs is special. Working with a professional peptide CDMO, the R&D and manufacturing system will be managed accordingly according to the compliance requirements of peptide drugs.
In the field of peptide drugs, Creative Peptides has laid out peptide APIs or formulations in the therapeutic areas of oncology, diabetes, cardiovascular diseases and other diseases, and realized the large-scale production of various peptides. Based on the solid/liquid phase peptide synthesis platform, we provide pharmacological research services from process development, to small pilot, pilot, process validation and quality study, as well as one-stop customized production services for drug development and commercial production.
Creative Peptides has well-equipped peptide production and testing facilities and a first-class professional development team in the field of peptides to support custom peptide services and peptide scale up production. We have established close cooperation with biotech and large pharmaceutical companies, and have extensive experience in peptide development, filing and production.
Creative Peptides always insists on providing high quality peptide products. Our testing program includes product purity, molecular weight, sequence identity, solvent residues, amino acid analysis, salt content, peptide content and endotoxin. Meanwhile, we can ensure batch stability and product quality.
Creative Peptides has extensive experience in peptide drug development, registration and manufacturing. We have development and production workshops that meet GMP and FDA filing requirements and have the ability to generate peptide APIs and cosmetic peptides on a large scale. Meanwhile, we have established a reliable quality management system and are committed to meet the peptide development needs of global customers.
Fig. 1 Synthesis of recombinant peptide
Equipped with advanced instruments such as UPLC, HPLC, preparative chromatography, LC-MS/MS, GC/MS, IC and controlled release formulation research equipment
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Elcatonin acetate, a physicochemically and biologically stable synthetic derivative of calcitonin transformed fr ...
PMX-53, a chemically synthesized peptide material, is a potent C5a antagonist in human neutrophils and macrophag ...
The cyclopentapeptide FC 131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-), 2-Nal=3-(2-naphthyl) alanine)) is an ...
Background Aclerastide, one angiotensin receptor agonist, is the active ingredient of DSC127 and its general structure is sho ...
MEN 11270 (H-DArg-Arg-Pro-Hyp-Gly-Thi-c(Dab-Dtic-Oic-Arg)c(7γ-10α)) is a novel selective constrained peptide ant ...